Latest Manufacturing News

Page 19 of 335
Island Pharmaceuticals has secured approvals to use Galidesivir in Uganda’s Bundibugyo Ebola outbreak while advancing two complementary Marburg studies and expanding manufacturing. The progress comes with a sharper funding question: cash fell to A$7.83 million after quarterly operating outflows of A$4.93 million, leaving an estimated 1.6 quarters of funding.
Victor Sage
Victor Sage
26 Oct 2026
Anax Metals has moved its Whim Creek copper-zinc project deeper into engineering and financing work, while Mons Cupri’s Mineral Resource rises 24% to 6.32 million tonnes. The company is still targeting a fourth-quarter Final Investment Decision, but funding remains non-binding and the larger resource has yet to enter the project’s Ore Reserve or financial forecasts.
Maxwell Dee
Maxwell Dee
26 Oct 2026
Firebird Metals has improved the packing density, particle morphology and impurity profile of its lithium-manganese-rich precursor material, with tap density reaching 1.35 g/cm³ and sulphur falling 46% to 610 ppm. The results strengthen the technical case for the platform, but downstream cathode testing and larger-scale validation remain ahead.
Victor Sage
Victor Sage
26 Oct 2026
FINEOS lifted its quarterly client receipts 47% and ended September with €51.7 million in cash, while maintaining FY26 revenue guidance of €147 million to €152 million. The stronger cash position was helped by the delayed collection of approximately €8 million in invoices, but no new sales were finalised during the quarter.
Victor Sage
Victor Sage
26 Oct 2026
Electro Optic Systems has expanded its defence pipeline sharply, with an unconditional A$717 million order book and a conditional Kuwait contract that could add about A$700 million. The opportunity comes with substantial guarantee, working-capital and export-licensing requirements.
Victor Sage
Victor Sage
26 Oct 2026
Beam Communications delivered positive operating cashflow of $160,000 in Q1FY27 despite a much smaller post-Zoleo revenue base, while core hardware sales lifted quarterly revenue by 20.2%. The company expects positive operating cashflow to continue through FY27, but recurring revenue and SatPhone Shop sales weakened.
Victor Sage
Victor Sage
26 Oct 2026
6K Additive delivered 61% year-on-year revenue growth in the September quarter as its order backlog jumped 52% to US$18.1 million. The company is pairing that demand with a funded manufacturing expansion, but the next test is converting commitments into production and cash.
Victor Sage
Victor Sage
26 Oct 2026
AML3D has secured an approximately $2.2 million order from Northrop Grumman Marine Systems for a large-scale ARCEMY X metal additive manufacturing system. The contract gives AML3D its first engagement with the US defence prime and expands its contracted US base to 17 ARCEMY systems.
Victor Sage
Victor Sage
26 Oct 2026
Janus Electric has signed a non-binding MOU with ConGlobal for a proposed 20-truck Class 8 conversion pilot in Texas. A successful pilot could open a pathway to conversion, battery-swapping and servicing operations across ConGlobal’s 31 US depots, although no binding orders or commercial terms have been agreed.
Victor Sage
Victor Sage
26 Oct 2026
Pure Foods Tasmania reported a sharper September quarter, with customer receipts rising to A$1.22 million while operating cash outflow fell to A$311,000. The company remains cash flow negative and reliant on financing capacity, but says the figures mark progress towards a sustainable turnaround.
Victor Sage
Victor Sage
26 Oct 2026
Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.
Victor Sage
Victor Sage
26 Oct 2026
Biome Australia has reported record pharmacy sell-through, further market-share gains and positive operating cash flow as it begins manufacturing Activated Probiotics domestically. The quarter also moved its China expansion and BMB18 clinical trial closer to key execution milestones.
Ada Torres
Ada Torres
26 Oct 2026

Browse the archive

Full archive